Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial [Pediatric Oncology]

Posted by rob on July 31, 2011 under Uncategorized | Comments are off for this article

Conclusion
Imatinib is effective in children with CML in CP with response rates similar to rates reported in adults. The adverse effects are acceptable, but longer follow-up studies are required to fully assess the long-term impact. (Source: Journal of Clinical Oncology)
More